Cargando…

Barriers to optimizing inflammatory bowel disease care in the United States

Significant progress in the management and modification of inflammatory bowel disease (IBD) has been made; however, significant barriers to the optimization of IBD care in the United States still exist. The majority of these barriers are constructed by insurance carriers and the integration of marke...

Descripción completa

Detalles Bibliográficos
Autores principales: Spencer, Elizabeth A., Abbasi, Sadeea, Kayal, Maia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164253/
https://www.ncbi.nlm.nih.gov/pubmed/37163167
http://dx.doi.org/10.1177/17562848231169652
_version_ 1785038032800317440
author Spencer, Elizabeth A.
Abbasi, Sadeea
Kayal, Maia
author_facet Spencer, Elizabeth A.
Abbasi, Sadeea
Kayal, Maia
author_sort Spencer, Elizabeth A.
collection PubMed
description Significant progress in the management and modification of inflammatory bowel disease (IBD) has been made; however, significant barriers to the optimization of IBD care in the United States still exist. The majority of these barriers are constructed by insurance carriers and the integration of market pressures into healthcare decision-making. In this review, we highlight the barriers to IBD care optimization within the context of the US insurance system and review current and proposed solutions.
format Online
Article
Text
id pubmed-10164253
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-101642532023-05-08 Barriers to optimizing inflammatory bowel disease care in the United States Spencer, Elizabeth A. Abbasi, Sadeea Kayal, Maia Therap Adv Gastroenterol IBD Barriers Across the Continents Significant progress in the management and modification of inflammatory bowel disease (IBD) has been made; however, significant barriers to the optimization of IBD care in the United States still exist. The majority of these barriers are constructed by insurance carriers and the integration of market pressures into healthcare decision-making. In this review, we highlight the barriers to IBD care optimization within the context of the US insurance system and review current and proposed solutions. SAGE Publications 2023-05-05 /pmc/articles/PMC10164253/ /pubmed/37163167 http://dx.doi.org/10.1177/17562848231169652 Text en © The Author(s), 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle IBD Barriers Across the Continents
Spencer, Elizabeth A.
Abbasi, Sadeea
Kayal, Maia
Barriers to optimizing inflammatory bowel disease care in the United States
title Barriers to optimizing inflammatory bowel disease care in the United States
title_full Barriers to optimizing inflammatory bowel disease care in the United States
title_fullStr Barriers to optimizing inflammatory bowel disease care in the United States
title_full_unstemmed Barriers to optimizing inflammatory bowel disease care in the United States
title_short Barriers to optimizing inflammatory bowel disease care in the United States
title_sort barriers to optimizing inflammatory bowel disease care in the united states
topic IBD Barriers Across the Continents
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164253/
https://www.ncbi.nlm.nih.gov/pubmed/37163167
http://dx.doi.org/10.1177/17562848231169652
work_keys_str_mv AT spencerelizabetha barrierstooptimizinginflammatoryboweldiseasecareintheunitedstates
AT abbasisadeea barrierstooptimizinginflammatoryboweldiseasecareintheunitedstates
AT kayalmaia barrierstooptimizinginflammatoryboweldiseasecareintheunitedstates